Clinical Management of Acute HIV Infection: Best Practice Remains Unknown

被引:42
作者
Bell, Sigall K. [2 ]
Little, Susan J. [3 ]
Rosenberg, Eric S. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[3] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; TRANSMITTED DRUG-RESISTANCE; T-CELL RESPONSES; VIRAL LOAD; TYPE-1; INFECTION; RESTORATION; ZIDOVUDINE; IMPACT; REPLICATION;
D O I
10.1086/655655
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Best practice for the clinical management of acute human immunodeficiency virus (HIV) infection remains unknown. Although some data suggest possible immunologic, virologic, or clinical benefit of early treatment, other studies show no difference in these outcomes over time, after early treatment is discontinued. The literature on acute HIV infection is predominantly small nonrandomized studies, which further limits interpretation. As a result, the physician is left to grapple with these uncertainties while making clinical decisions for patients with acute HIV infection. Here we review the literature, focusing on the potential advantages and disadvantages of treating acute HIV infection outlined in treatment guidelines, and summarize the presentations on clinical management of acute HIV infection from the 2009 Acute HIV Infection Meeting in Boston, Massachusetts.
引用
收藏
页码:S278 / S288
页数:11
相关论文
共 73 条
[61]   HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy [J].
Steingrover, Radjin ;
Pogany, Katalyn ;
Garcia, Evian Fernandez ;
Jurriaans, Suzanne ;
Brinkman, Kees ;
Schuitemaker, Hanneke ;
Miedema, Frank ;
Lange, Joep M. A. ;
Prins, Jan M. .
AIDS, 2008, 22 (13) :1583-1588
[62]   Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection [J].
Streeck, Hendrik ;
Jessen, Heiko ;
Alter, Galit ;
Teigen, Nickolas ;
Waring, Mike T. ;
Jessen, Arne ;
Stahmer, Ingrid ;
van Lunzen, Jan ;
Lichterfeld, Mathias ;
Gao, Xiaojiang ;
Allen, Todd M. ;
Carrington, Mary ;
Walker, Bruce D. ;
Rockstroh, Juergen K. ;
Altfeld, Marcus .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (06) :734-739
[63]   Primary HIV-1 infection: Diagnosis and prognostic impact [J].
Vanhems, P ;
Lecomte, C ;
Fabry, J .
AIDS PATIENT CARE AND STDS, 1998, 12 (10) :751-758
[64]   Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe [J].
Vercauteren, Jurgen ;
Wensing, Annemarie M. J. ;
van de Vijver, David A. M. C. ;
Albert, Jan ;
Balotta, Claudia ;
Hamouda, Osamah ;
Kuecherer, Claudia ;
Struck, Daniel ;
Schmit, Jean-Claude ;
Asjo, Birgitta ;
Bruckova, Marie ;
Camacho, Ricardo J. ;
Clotet, Bonaventura ;
Coughlan, Suzie ;
Grossman, Zehava ;
Horban, Andrzej ;
Korn, Klaus ;
Kostrikis, Leondios ;
Nielsen, Claus ;
Paraskevis, Dimitrios ;
Poljak, Mario ;
Puchhammer-Stoeckl, Elisabeth ;
Riva, Chiara ;
Ruiz, Lidia ;
Salminen, Mika ;
Schuurman, Rob ;
Sonnerborg, Anders ;
Stanekova, Danica ;
Stanojevic, Maja ;
Vandamme, Anne-Mieke ;
Boucher, Charles A. B. .
JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (10) :1503-1508
[65]   Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells [J].
Verhoeven, David ;
Sankaran, Sumathi ;
Silvey, Melanie ;
Dandekar, Satya .
JOURNAL OF VIROLOGY, 2008, 82 (08) :4016-4027
[66]   Early postinfection antiviral treatment reduces viral load and prevents CD4(+) cell decline in HIV type 2-infected macaques [J].
Watson, A ;
McClure, J ;
Ranchalis, J ;
Scheibel, M ;
Schmidt, A ;
Kennedy, B ;
Morton, WR ;
Haigwood, NL ;
Hu, SL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (16) :1375-1381
[67]  
Zala C, 2002, J ACQ IMMUN DEF SYND, V29, P368, DOI 10.1097/00126334-200204010-00007
[68]  
2009, SHORT COURSE ANTIRET
[69]  
2005, ANTIHIV MED PEOPLE R
[70]  
2008, PILOT STUDY RALTEGRA